欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2020/001
药品名称
Gaxenim
活性成分
fingolimod hydrochloride 0.5 mg
剂型
Capsule, hard
上市许可持有人
Bausch Health Ireland Limited, Ireland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Filival 0,5 mg Hartkapseln
Denmark (DK)
Spain (ES)
Italy (IT)
Finland (FI)
Poland (PL)
Bulgaria (BG)
Gaxenim
Hungary (HU)
Semfine 0,5 mg kemény kapszula
Czechia (CZ)
Filival
Slovakia (SK)
许可日期
2020/12/02
最近更新日期
2024/11/07
药物ATC编码
L04AE01 fingolimod
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_2020_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_2020_001_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_2020_01_DC
Date of last change:2024/09/06
PubAR Summary
|
SE_H_2020_01_DC_2
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase